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On behalf of the International AIDS Society (IAS), Med-
scape, and our editors, we are pleased to introduce eJIAS:
eJournal of the International AIDS Society, a new peer-
reviewed journal dedicated to the science and practice of
HIV/AIDS medicine in the developing world. And, on the
occasion of the largest international gathering of HIV/
AIDS scientists and healthcare and public health workers
in 2 years, we are privileged to present the official online
abstracts of the XV International AIDS Conference (Bang-
kok, Thailand; July 1116, 2004) in this inaugural issue of
eJIAS.
eJIAS www.eJIAS.org is an online, primary-source, peer-
reviewed medical journal created to foster publication by
researchers from developing countries and to enhance the
accessibility and exchange of essential HIV/AIDS knowl-
edge among frontline scientists, healthcare providers, and
public health professionals working in diverse, but com-
monly resource-limited, settings. Copublished by IAS and
Medscape, eJIAS is the first and only HIV/AIDS journal
specifically for the publication of original, peer-reviewed
articles that are highly relevant to the study, prevention,
and treatment of HIV/AIDS in the developing world.
In keeping with the theme of the XV International AIDS
Conference, "Access for All," eJIAS seeks to encourage and
facilitate publication by scientists and clinicians working
in developing countries, and to thereby improve the dis-
semination of high-quality medical evidence from
research conducted in a diversity of geographic, cultural,
socioeconomic, and clinical settings. The 2-fold objective
of these efforts is to enhance the quality and exchange of
vital frontline HIV/AIDS data and knowledge, and to ena-
ble scientists and healthcare personnel to remain
informed about research, analysis, and opinion relevant
to the delivery of HIV/AIDS prevention, treatment, and
care in developing countries and on a global scale.
eJIAS is available free of charge wherever there is a Web
connection. To increase the accessibility and useful adop-
tion of the journal, the contents of eJIAS are published in
parallel, and indexed for MEDLINE, in Medscape General
Medicine  www.MedGenMed.com, Medscape's veteran,
MEDLINE-indexed general-medicine journal. Through
this unique collaborative approach and the combined
membership, publishing, and program experience of IAS
and Medscape, the research contributions and frontline
perspectives published in eJIAS will reach more than 2
million healthcare professionals in 249 countries.
We are grateful to the Bristol-Myers Squibb Foundation
for making the creation and launch of eJIAS  possible
through a founding grant from their Secure the Future
program.
With this announcement, we dedicate eJIAS to our col-
leagues who are striving to change the course of AIDS
around the world. It is our sincere hope that eJIAS will
serve, creatively and consistently, to advance their best
efforts and elevate the quality of research, information
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sharing, and education that must attend expanding global
HIV/AIDS care initiatives.
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